CME Live Meeting

ADVANCES IN DIABETES: WHAT'S NEW IN 2025?

Date: 7th November 2025

Time: 3:30 PM to 4:30 PM BST

Our Faculty

Speaker

Lyndon

Prof. Dr Lyndon Marc Evans

MB, BCh, FRCP, MD

  • Dr Evans is a Consultant Diabetologist at the University Hospital of Llandough in Cardiff, where he has held this position since 2003.
  • He has a very active research interest, particularly in the fields of health economics, health outcomes, epidemiology, and pharmacoepidemiology.
  • He has published over 200 peer-reviewed papers and abstracts across these fields and has also supported various Health Technology Assessment (HTA) submissions for differing novel therapies across a variety of disease areas.
  • He is currently Editor-in-Chief of Diabetes Therapy, a journal specifically focused on therapeutic issues in diabetes.

Moderator

Dr_Rajiv_Awasthi

Dr. Rajiv Awasthi

MD (KGMC), FICP, FISH, FIACM

  • Dr Rajiv Awasthi is the Director of Prarthana Clinic & Diabetes Care Centre, Lucknow with over 35 years of experience.
  • He is the President of the Lucknow Diabetes Study Group and the Past Chairman of the Association of Physicians of India (API), Lucknow Chapter.
  • He has completed training fellowship in Diabetes at the Joslin Institute, USA, and the Baker Institute, Australia.
  • Dr Awasthi has presented his research at eminent gatherings such as the European Association for the Study of Diabetes (EASD), and the American Diabetes Association (ADA).

LEARNING OBJECTIVES

  • Discuss the leveraging advancements in Diabetes technology
  • Consideration of CGM and CKM use for adults with T2D on glucose-lowering agents other than insulin
  • Glycaemic goals and pharmacologic approaches to glycaemic treatment: standards of care in diabetes—2025.
  • Managing T2D with high CV risk and CKD - Incorporating drugs showing benefits beyond glycaemic control
  • Recent advances and clinical advantages of GLP-1 receptor agonists in treating T2D and related metabolic conditions.
  • Diabetes digital transformation

  • Abbreviations: CV, cardiovascular; CGM, continuous glucose monitoring; CKM, continuous ketone monitoring; GLP-1, glucagon-like peptide-1; T2D, type 2 diabetes

Agenda 7th November 2025

5

Mins.

Introductions & Context Setting

Dr Rajiv Awasthi

30

Mins.

Advances in Diabetes: What’s New in 2025?

Prof. Dr Lyndon Marc Evans

20

Mins.

Q & A Session

All faculties

5

Mins.

Take Home Message

Copyright: All rights reserved. No part of this website content may be reproduced, stored in retrieval system, tapes, discs, microfilms etc., or transmitted in any form or by any means electronic, mechanical, photocopies, recording or otherwise, without the written permission of Insignia Learning Pvt. Ltd., Mumbai.